CLLS
Cellectis S.A.
Phase 2
AI-extracted
lasme-cel
relapsed or refractory B-cell acute lymphoblastic leukemia (r/r B-ALL)
52d ago
~ Oct 1, 2026
SEC 6-K
verified 5mo ago
Countdown card β